Primary Membranous Nephropathy Clinical Trials

15 recruiting

Frequently Asked Questions

Common questions about Primary Membranous Nephropathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 3

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

Primary Membranous Nephropathy
Biogen180 enrolled85 locationsNCT06962800
Recruiting
Phase 2

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences96 enrolled50 locationsNCT06466135
Recruiting
Phase 2Phase 3

A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

Primary Membranous Nephropathy
Vertex Pharmaceuticals Incorporated176 enrolled73 locationsNCT07204275
Recruiting
Phase 1Phase 2

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

Lupus NephritisPrimary Membranous Nephropathy
Nkarta, Inc.96 enrolled16 locationsNCT06557265
Recruiting
Phase 2

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

Primary Membranous Nephropathy
Alexion Pharmaceuticals, Inc.30 enrolled39 locationsNCT07157787
Recruiting
Phase 2

A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy

Primary Membranous Nephropathy
Climb Bio, Inc.45 enrolled33 locationsNCT07096843
Recruiting
Phase 2

Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

Primary Membranous Nephropathy
Guangdong Hengrui Pharmaceutical Co., Ltd75 enrolled1 locationNCT07289763
Recruiting
Phase 3

OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)

Primary Membranous Nephropathy
Huashan Hospital144 enrolled1 locationNCT06781944
Recruiting
Phase 1

Study of YK012 in Primary Membranous Nephropathy

Primary Membranous Nephropathy
Excyte Biopharma Ltd72 enrolled1 locationNCT06982729
Recruiting

A Real World Study About PMN

Primary Membranous Nephropathy
Wei Chen200 enrolled1 locationNCT06893328
Recruiting
Phase 1

Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001

Primary Membranous Nephropathy
Everest Medicines (China) Co.,Ltd.30 enrolled19 locationsNCT05800873
Recruiting
Phase 2Phase 3

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd216 enrolled21 locationsNCT06470191
Recruiting
Phase 1

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd52 enrolled6 locationsNCT05668403
Recruiting
Phase 3

A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc.148 enrolled31 locationsNCT05696613
Recruiting
Phase 4

Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

Primary Membranous Nephropathy
First Affiliated Hospital, Sun Yat-Sen University78 enrolled1 locationNCT05514015